High-Intensity Laser Therapy Versus Shockwave Therapy in Osteoporotic Long Term Hemiparetic Patients
1 other identifier
interventional
120
1 country
1
Brief Summary
Background: The relationship between immobilization and localized osteoporosis is well documented in chronic stroke patients. Hemiparetic patients are predisposed to fractures and usual activity impairment due to a considerable loss of bone density. A serious health care challenge is finding ways to reduce osteoporosis and associated fractures among stroke survivors. This study aimed to compare the effects of HILT and ESWT in treating osteoporosis and its consequences in hemiparetic patients. Patients and Methods: A randomized controlled trial was performed at the Faculty of Physical Therapy Outpatient Clinic, Cairo University. One hundred and twenty hemiplegic patients with osteoporosis of both sexes were chosen randomly. They were randomly classified into three equal groups (n=40 in each group). The control group received medication and traditional physiotherapy programs for stroke patients (strengthening, stretching, and balance exercise). The high-intensity laser (HIL) group received the same intervention as the control group in addition to high-intensity laser therapy. The shock wave (SW) group received the same intervention as the control group in addition to shock wave therapy. The three groups received an intervention that lasted 3 sessions/week for 12 weeks). All groups were assessed before and after therapy (3 months) for the degree of pain, which was evaluated by visual analog scale (VAS), fall risk assessment (overall stability index and Short Form of Berg Balance Scale (SFBBS)), and Quality of Life Questionnaire of the European Foundation for Osteoporosis (QUALEFFO-41).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Oct 2021
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2022
CompletedFirst Submitted
Initial submission to the registry
November 1, 2022
CompletedFirst Posted
Study publicly available on registry
November 15, 2022
CompletedNovember 15, 2022
November 1, 2022
5 months
November 1, 2022
November 7, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Quality of Life Questionnaire of the European Foundation for Osteoporosis (QUALEFFO-41)
Quality of Life Questionnaire of the European Foundation for Osteoporosis
12 weeks
Pain intensity
Visual analogue scale, a scale of 10 poi to 0 represent no pain at all and 10 represent the worst pain
12 weeks
fall risk assessment
Short Form of Berg Balance Scale ,(SFBBS) ranged from 0 poor balance to 28 good balance.consisted of 7 items each item has grades from 1 poor balance to 4 good balance
12 weeks
Study Arms (3)
Control group
ACTIVE COMPARATORcontrol group received medication and traditional physiotherapy programs for stroke patients (strengthening, stretching, and balance exercise)
high-intensity laser group
EXPERIMENTALThe high-intensity laser (HIL) group received the same intervention as the control group in addition to high-intensity laser therapy.
shock wave group
EXPERIMENTALshock wave (SW) group received the same intervention as the control group in addition to shock wave therapy.
Interventions
intervention that lasted 3 sessions/week for 12 weeks).
intervention that lasted 3 sessions/week for 12 weeks).
Eligibility Criteria
You may qualify if:
- All participants were diagnosed by Dual-energy X-ray absorptiometry (DEXA) as osteoporosis or osteopenia, where T-score was -1.5 or less.
- All patients were recruited from Kasr Al-Ainy Hospital, Cairo University.
You may not qualify if:
- BMI of more than 30 or less than 18
- Advanced musculoskeletal disorders.
- Rheumatoid arthritis.
- Skin diseases.
- Long-term steroids therapy, or any drug affecting bones.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Beni-Suef University
Banī Suwayf, Sharq, 11222, Egypt
Related Publications (1)
Abo Elyazed TI, Al-Azab IM, Abd El-Hakim AAE, Elkady SM, Afifi RMM, Obaya HE. Effect of high-intensity laser therapy versus shockwave therapy on selected outcome measures in osteoporotic long-term hemiparetic patients: a randomized control trial. J Orthop Surg Res. 2023 Sep 2;18(1):653. doi: 10.1186/s13018-023-04141-5.
PMID: 37660042DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Mohamed A Adel, Mr
Beni-Suef University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Ass.prof
Study Record Dates
First Submitted
November 1, 2022
First Posted
November 15, 2022
Study Start
October 1, 2021
Primary Completion
March 1, 2022
Study Completion
March 1, 2022
Last Updated
November 15, 2022
Record last verified: 2022-11
Data Sharing
- IPD Sharing
- Will not share
IPD will be available on personal request